Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Sign-on Letter Opposing the Patent Eligibility Restoraction Act of 2024
-
ACMG Reseponse to Alabama Supreme Court Decision on Embryos
-
Sign-on Letter Asking Congress to Make Medicare Telehealth Waivers Permanent
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
Coalition Letter for NBS Funding in FY 2024 Appropriations
-
Sign-on Letter to Congress Urging Reversal of 2024 Physician Payment Cuts
-
Amicus Brief for Kanuszewski v MDHHS (6th Circuit) – Newborn Screening Dried Blood Spot
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs
-
Sign-on Letter Asking Congress to Pass Legislation to Stop Pending Physician Payment Cuts
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Sign-on Letter Supporting Draft Legislation Addressing Budget Neutrality Impact to Physician Payment Rates
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs
